epcoritamab
abbvie,genmab
['epcoritamab', 'dlbcl']
promising activity of epcoritamab + rdhax/c in transplant eligible dlbcl. orr 85%, and cr 67%. mpfs and os not reached. this could be a potential bridging regimen. #ash22